Share Issue News

HOUSTON--(BUSINESS WIRE)--Corebridge Financial, Inc. (NYSE: CRBG) today announced that the previously announced secondary offering by American International Group, Inc. (NYSE: AIG) of common stock of Corebridge Financial has priced at $33.65 per share. The offering is expected to close on August 8, 2025, subject to customary closing conditions. AIG, as the selling stockholder, has offered 30 million existing shares of common stock (out of approximately 538 million total shares of common stock o...

HOUSTON--(BUSINESS WIRE)--Murphy Oil Corporation (NYSE: MUR): Murphy Oil Corporation Stockholders, This year Murphy Oil Corporation celebrates its 75th anniversary of incorporation. Over the last 75 years, Murphy has built a legacy based on a pioneering spirit and thoughtful decision making. Murphy is different from other independent exploration and production companies of its size. We have both onshore and offshore production, operate in the United States and internationally, and have a proven...

PARIS--(BUSINESS WIRE)--Regulatory News: Getlink SE (Paris: GET)   Presenter / Corporate name Getlink SE Société Européenne RCS Paris 483 385 142 37-39 rue de la Bienfaisance 75008 Paris Number of ordinary shares in issue (1) 550,000,000 Number of voting rights theoretical (2) (3) 785,290,138 Date 31 July 2025 Total number of exercisable voting rights at 31 July 2025 and not including the shares for which voting rights have been suspended: 777,216,719. * * * * (1) The share capital is divided i...

PEMBROKE, Bermuda--(BUSINESS WIRE)--Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or “the Company”), a global specialty insurer, announced today a significant expansion of its capital management initiatives. The Company's Board of Directors approved a renewal to the current common share repurchase authorization to $200 million and additionally approved an increase to the quarterly dividend to $0.15 per common share. This announcement builds on the $132.8 million in c...

CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Holdings Inc. (the “Company”) (NASDAQ: CCCS) today announced the pricing of the previously announced secondary offering of the Company’s common stock (the “Offering”) by affiliates of Advent International, L.P. (the “Selling Stockholders”) at a price to the public of $9.89 per share. The Offering consists of 30,000,000 shares of the Company’s common stock. The Offering is expected to close on or about August 7, 2025, subject to the satisfactio...

SAN ANTONIO--(BUSINESS WIRE)--Howard Midstream Energy Partners, LLC (the “Company”) today announced that it is commencing an offering (the “Offering”) of $600 million of senior notes due 2034 (the “2034 Notes”). The 2034 Notes will be issued in a private offering exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Company intends to use the net proceeds from the Offering to (i) fund the redemption of all of the $550.0 million aggregate principal amo...

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 180,000 shares of Astria’s common stock on August 1, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria. The options were gran...

PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): Date Total number of issued shares Number of real voting rights (excluding treasury shares) Theoretical number of voting rights (including treasury shares)* 31 July 2025 140,948,872 140,662,864 140,948,872 *Pursuant to article 223-11 of the Règlement Général de l’Autorité des marchés financiers. CARMILA French société anonyme with a share capital of €845,693,232 Registered office: 25, rue d’Astorg, 75008 Paris - France Registered at...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 181,450 shares of the company’s common stock to 4 new employees (th...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista’s board of directors granted six newly-hired employees inducement options to purchase an aggregate of 44,000 shares of KalVista common stock on August 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock o...